V A Levin
- Co-authors
- Michael D. PradosRobert L. DavisKwang Seok LeeMichael S. B. EdwardsTomoyuki HoshinoM. Fatih OkcuSanbao RuanMichael Andreeff
- Topics
- Retinoids in leukemia and cellular processes (3 papers)Glioma Diagnosis and Treatment (3 papers)Cancer-related Molecular Pathways (2 papers)
- Cited by
- GeneticsCancer ResearchOncology
- Journals
- Journal of neurosurgeryInternational Journal of Radiation Oncology*Biology*PhysicsInternational Journal of Oncology
- Partner nations
- United StatesJapan
In The Last Decade
V A Levin
7 papers receiving 453 citations
Peers
Comparison fields: 5 of 62
- Molecular Biology 232
- Genetics 183
- Oncology 129
- Cancer Research 80
- Pulmonary and Respiratory Medicine 61
Countries citing papers authored by V A Levin
This map shows the geographic impact of V A Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V A Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V A Levin more than expected).
Fields of papers citing papers by V A Levin
This network shows the impact of papers produced by V A Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V A Levin. The network helps show where V A Levin may publish in the future.
Co-authorship network of co-authors of V A Levin
This figure shows the co-authorship network connecting the top 25 collaborators of V A Levin. A scholar is included among the top collaborators of V A Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V A Levin. V A Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Biology and treatment of malignant glioma. | 175 |
| 2 | 9 | |
| 3 | Fenretinide activates caspases and induces apoptosis in gliomas. | 35 |
| 4 | Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. | 43 |
| 5 | Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. | 71 |
| 6 | 2 | |
| 7 | 131 |
About V A Levin
V A Levin is a scholar working on Genetics, Biochemistry and Oncology, having authored 7 papers that have together received 466 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (3 papers), Glioma Diagnosis and Treatment (3 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Genetics (183 citations), Cancer Research (80 citations) and Oncology (129 citations). V A Levin has collaborated with scholars based in United States and Japan. Frequent co-authors include Michael D. Prados, Robert L. Davis, Kwang Seok Lee, Michael S. B. Edwards, Tomoyuki Hoshino, M. Fatih Okcu, Sanbao Ruan, Michael Andreeff, Jianping Ren and Paul J. Chiao. Their work appears in journals such as Journal of neurosurgery, International Journal of Radiation Oncology*Biology*Physics and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.